Evidence map›Paper›PMID 10850810›Full record

ArticleProtein science : a publication of the Protein Society2000

Characterization of an anti-Borrelia burgdorferi OspA conformational epitope by limited proteolysis of monoclonal antibody-bound antigen and mass spectrometric peptide mapping.

V Legros, C Jolivet-Reynaud, N Battail-Poirot, C Saint-Pierre, E Forest

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Identification ofFrontiers in immunology · 2025
    Article
  2. Review
  3. Human and Veterinary Vaccines for Lyme Disease.Current issues in molecular biology · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Epitope mapping of Borrelia burgdorferi OspC protein in homodimeric fold.Protein science : a publication of the Protein Society · 2017
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

V LegrosInstitut de Biologie Structurale (CEA-CNRS-UJF), Laboratoire de Spectrométrie de Masse des Protéines, Grenoble, France.
C Jolivet-Reynaud
N Battail-Poirot
C Saint-Pierre
E Forest
bioMérieux (France) · FRCEA Grenoble · FRUniversité Grenoble Alpes · FRUniversité Joseph Fourier · FRZimmer Biomet (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lyme borreliosis is a multisystem disorder caused by the spirochete Borrelia burgdorferi that is transmitted to humans by the tick Ixodes dammini. The immune response against the 31 kDa OspA, which is one of the most abundant B. burgdorferi proteins, appears to be critical in preventing infection and tissue inflammation. Detailed knowledge of the immunological and molecular characteristics of the OspA protein is important for the development of reliable diagnostic assays. In this study, we characterized a new conformational epitope present within the middle part of B. burgdorferi OspA. Our approach used enzymatic proteolyses of the immune complex followed by mass spectrometric identification of the peptides bound to the antibody. It appears to be one of the first reports on the characterization of a discontinuous epitope using mass spectrometry.

Indexed as

LipoproteinsAnimalsAntibodies, MonoclonalAntigensAntigens, SurfaceBacterial Outer Membrane ProteinsBacterial VaccinesBlotting, WesternBorrelia burgdorferi GroupCell LineChromatography, AgaroseCyanogen BromideElectrophoresis, Polyacrylamide GelEnzyme-Linked Immunosorbent AssayEpitopesFemaleAntibodies, MonoclonalAntigensAntigens, SurfaceBacterial Outer Membrane ProteinsBacterial VaccinesCyanogen BromideEpitopesGlycineIonsLipoproteinsLyme Disease VaccinesOspA proteinPeptidesRecombinant Proteins

Identifiers

PMID10850810
PMCPMC2144631
OpenAlexW2149492388

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.